A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.
Amelia ShoemarkErin CantLuis CarretoAlexandria SmithMartina OrianoHolly R KeirLidia PereaElisabet CantoLeonardo TerranovaSilvia VidalKelly MoffittStefano AlibertiOriol SibilaJames D ChalmersPublished in: The European respiratory journal (2019)
A novel lateral flow device provides assessment of neutrophil elastase activity from sputum in minutes and identifies patients at increasing risk of airway infection and future exacerbations.